Silverberg Bernstein Capital Management’s Apyx Medical APYX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.02M | Buy |
896,736
+250,167
| +39% | +$563K | 1.38% | 19 |
|
|
2025
Q1 | $886K | Buy |
646,569
+75,337
| +13% | +$103K | 0.82% | 32 |
|
|
2024
Q4 | $903K | Sell |
571,232
-1,400
| -0.2% | -$2.21K | 0.79% | 29 |
|
|
2024
Q3 | $710K | Sell |
572,632
-23,855
| -4% | -$29.6K | 0.65% | 34 |
|
|
2024
Q2 | $799K | Sell |
596,487
-24,900
| -4% | -$33.4K | 0.77% | 30 |
|
|
2024
Q1 | $845K | Buy |
621,387
+7,507
| +1% | +$10.2K | 0.83% | 30 |
|
|
2023
Q4 | $1.61M | Buy |
+613,880
| New | +$1.61M | 1.53% | 15 |
|